Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 276

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Trial of relaxation in reducing coronary risk: four year follow up.

Open access
Patel, C, Marmot, M G, Terry, D J, Carruthers, M, Hunt, B, Patel, M · 1985 · BMJ

Abstract

On screening 192 men and women aged 35-64 were identified as having two or more of the following risk factors: blood pressure greater than or equal to 140/90 mm Hg, plasma cholesterol concentration greater than or equal to 6.3 mmol/l (243.6 mg/100 ml), and current smoking habit greater than or equal to 10 cigarettes a day. They were randomly allocated to a group for modification of behaviour or to serve as controls. Both groups were given health education leaflets containing advice to stop smoking, to reduce animal fats in the diet, and on the importance of reducing blood pressure. In addition, the treatment group had group sessions of one hour a week for eight weeks in which they were taught breathing exercises, relaxation, and meditation and about managing stress. It had previously been found that after eight weeks and eight months there was a significantly greater reduction in both systolic and diastolic blood pressures in the group taught to relax compared with the control group. After four years of follow up these differences in blood pressure were maintained. Plasma cholesterol concentration and the number of cigarettes smoked were lower in the treatment group at eight weeks and eight months but not at the four year follow up. At four years more subjects in the control group reported having had angina and treatment for hypertension and its complications. Incidence of ischaemic heart disease, fatal myocardial infarction, or electrocardiographic evidence of ischaemia was significantly greater in the control group. If the results of this study could be obtained in a larger study the financial and health care implications would be enormous.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.290.6475.1103

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 4

  1. Irvine MJ. A controlled study of relaxation and stress management in the treatment of essential hypertension. Oxford: University of Oxford, 1983. (DPhil thesis.)
  2. Patel C. Reduction of serum cholesterol and blood pressure in hypertensive patients by behaviour modification. J R Coll Gen Pract 1976;26:211-5.
  3. Patel C, Carruthers M. Coronary risk factor reduction through biofeedbackaided relaxation and medication. 7 R Coll Gen Pract 1977;27:401-5.
  4. A survey of notifications of tuberculosis in England and Wales in 1978 showed that disease of the lymph nodes was the commonest form of non-respiratory tuberculosis.' The British Thoracic Association's first controlled trial of chemotherapy for tuberculosis of lymph nodes compared two 18 month regimens in 90 patients.2 3 The regimens comprised either rifampicin plus isoniazid or ethambutol plus isoniazid, both supplemented with streptomycin for the first two months. A satisfactory response to chemotherapy was seen, and microbiological relapse did not occur when treatment was stopped. In a retrospective study of lymph node tuberculosis Summers and McNicol reported no relapse in 239 patients, some of whom were treated with nine month regimens incorporating rifampicin and isoniazid.4

Cited by

See all 276

Metadata

Authors
Patel, C., Marmot, M. G., Terry, D. J., Carruthers, M., Hunt, B., & Patel, M.
Venue
BMJ
Publisher
BMJ
Published
1985-04-13
Volume
290
Issue
6475
Pages
1103-1106
ISSN
  • 0007-1447 (ISSN-L)
  • 0267-0623
  • 1468-5833
OpenAlex
W2077840874
Cited by
276
References
20
FWCI
15.43
Type
journal article
Language
en
Open access
bronze
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trial of relaxation in reducing coronary risk: four year follow up. https://app.cochat.ai/papers/10.1136/bmj.290.6475.1103
The paper
Patel, C., Marmot, M. G., Terry, D. J., Carruthers, M., Hunt, B., & Patel, M. (1985). Trial of relaxation in reducing coronary risk: four year follow up. BMJ. https://doi.org/10.1136/bmj.290.6475.1103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.